Blair William & CO Immunity Bio, Inc. Transaction History
Blair William & CO
- $33.5 Billion
- Q4 2024
A detailed history of Blair William & CO transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Blair William & CO holds 233,500 shares of IBRX stock, worth $679,485. This represents 0.0% of its overall portfolio holdings.
Number of Shares
233,500
Previous 206,800
12.91%
Holding current value
$679,485
Previous $767,000
22.16%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding IBRX
# of Institutions
229Shares Held
82.3MCall Options Held
1.02MPut Options Held
2.25M-
Vanguard Group Inc Valley Forge, PA17.3MShares$50.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$33.2 Million0.0% of portfolio
-
State Street Corp Boston, MA9.79MShares$28.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.01MShares$11.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.84MShares$11.2 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.16B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...